Liver cancer treatment costly for Medicare patients, UT Southwestern study finds: Newsroom
Liver cancer is forecast to be the No. 3 induce of cancer deaths by 2040, said Dr. Amit Singal and his colleagues. Cancer procedure fees in the United States are expected to approach $250 billion by 2030. (Image credit history: Getty Photos) DALLAS – Jan. 30, 2023 – Hepatocellular carcinoma (HCC), the most widespread style of liver most cancers, can area a substantial economic burden on patients, in accordance to an examination led by a researcher at UT Southwestern Health-related Heart. Amit…
